Shivom is powering the next era of genomics through blockchain technology – by protecting identity, personalizing healthcare, transforming lives. Our blockchain based genomics and healthcare platform will allow the transition to value-based precision healthcare. Our focus is on the transformational convergence of OMICS technologies with blockchain, artificial intelligence and machine learning to enable secure and personalized medicine with global scalability.
SHIVOM is building the largest genomic and health data hub around the globe by combining blockchain, genomic DNA sequencing, artificial intelligence and cryptography to power secure and personalized medicine.
Everybody will be able to get their genome sequenced and securely stored, and our ecosystem will offer an open web-marketplace for providers to add their apps and services alongside advanced data analytics. The SHIVOM platform works on principles of collaboration and integrity, allowing people to own, manage and monetize their genomics and health data. As we build this global healthcare ecosystem, we will reach even underserved and low-income countries where such services have not been previously available.
Our solution will create shared value for individuals, not-for-profit organizations, governments, and for-profit entities alike.
We have partnered with the top developers and healthcare organizations, and technology companies and big pharma are already lining up to take advantage of our unique genomics and healthcare approach. As Shivom scales up and goes global, we have many more partnerships already in development.
The platform is truly pioneering in the way it utilizes blockchain technology, to protect, secure and monetize the donor’s DNA data to drive precision medicine and healthcare forward.
All ratings published on ICObench serve informational purposes only. ICObench does not provide investment forecast, recommendations or any consulting for that matter. Thus, neither ICObench, nor the experts can be hold responsible for the visitors’ investment decisions. Read more
Experts are independently and voluntarily contributing to the community. If no expert has rated the ICO, only ICO analyzer's results are used. Always research before investing as these ratings should not be taken as an investing guide of any kind.
Ratings and ICO analyzer results are being updated (re-calculated) every few hours.
Shivom foundation established. Foundation director and first steering committee members on board.
7
Q1, 2018
Partnership major crypto vc.
8
April, 2018
Partnership medical center. Collaboration with first of many large clinical centers.Project gaia started. Sequencing project in rural India commenced. Platform alpha release.
9
Q2, 2018
Partnership major data analytics firm. Co -development to connect Shivom platform with stat-of-the art data analytics pipeline. Pharma partner on board. Collaboration with Top 25 pharmaceutical company.
10
Q2-Q3, 2018
Web marketplace open.
11
Q3-Q4, 2018
Formation R&D unit. Official start of global not-forprofit pharmaceutical spin-of. Worldwide rollout of Shivom platform. Shivom services are available on a global scale on all continents.
12
Q4, 2018
First rare- disease subset. Set of large group of people sequenced with rare disease. First genomics service unit opens. First genomics counseling service unit opens.
13
Q4 2018 - Q1 2019
Multi-omics integration. A.I. platform. Implementation of artificial intelligence, deep learning platform.
